Applied Therapeutics Q3 2023 EPS $(0.47) Down From $(0.40) YoY
Portfolio Pulse from Benzinga Newsdesk
Applied Therapeutics reported Q3 2023 earnings per share (EPS) of $(0.47), a decrease from $(0.40) year-over-year (YoY).
November 09, 2023 | 1:42 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Applied Therapeutics' Q3 2023 EPS decreased to $(0.47) from $(0.40) YoY, indicating a worsening financial performance.
Earnings per share (EPS) is a key indicator of a company's profitability. A decrease in EPS typically has a negative impact on a company's stock price as it indicates a worsening financial performance. In this case, Applied Therapeutics' Q3 2023 EPS decreased YoY, which could negatively impact the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100